Furthermore, polydatin has been identified as a promising therapeutic agent that, by targeting different states of the NLRP3 inflammasome complex, shows potential in treating acute pancreatitis (AP) and other NLRP3-related inflammatory diseases. The gene discussed is NLRP3; the disease is alkaline phosphatase measurement.